Found: 3
Select item for more details and to access through your institution.
Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment.
- Published in:
- Patient Preference & Adherence, 2024, v. 18, p. 1729, doi. 10.2147/PPA.S460994
- By:
- Publication type:
- Article
Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 7, p. 611, doi. 10.1007/s40261-022-01170-6
- By:
- Publication type:
- Article
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 1, p. 72, doi. 10.1093/oncolo/oyac186
- By:
- Publication type:
- Article